emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

First Page		Document Content
Date: 2015-07-08 04:50:21 Pharmaceuticals policy Health Pharmaceutical industry Pharmacology European Medicines Agency European Union Marketing authorization European Directorate for the Quality of Medicines EudraLex European Pharmacopoeia Orphan drug Supplementary protection certificate		emea_strap_url_cmyk_rev_en_std_cent.eps MASTER Add to Reading List Source URL: www.hma.eu Download Document from Source Website File Size: 535,20 KB Share Document on Facebook

	EC REVIEW OF THE ATMP REGULATION – CELL THERAPY CATAPULT RESPONSES 1 Introduction It is clear from the very small number of MAA approved to date that the registration process for ATMPs is complex and not easily satisfi DocID: 1r7q1 - View Document
	EUROPEAN PATIENTS’ RIGHTS DAY: 10 benefits the EU brings to patients A high level of health protection; the right to benefit from medical treatment; access to healthcare - preventive, diagnostic and curative treatment DocID: 1r2EM - View Document
	emea_strap_url_cmyk_rev_en_std_cent.eps MASTER DocID: 1qVx6 - View Document
	Annual ReportHIGHLIGHTS OF THE YEAR Establishing better regulation for selfcare products was the guiding principle for AESGP during the course of the last 12 months. Well attended conferences and association m DocID: 1pHPc - View Document
	B.12 AF user guide consolidated vet version EMA DocID: 1pz2w - View Document